AU5408999A - Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound - Google Patents

Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound

Info

Publication number
AU5408999A
AU5408999A AU54089/99A AU5408999A AU5408999A AU 5408999 A AU5408999 A AU 5408999A AU 54089/99 A AU54089/99 A AU 54089/99A AU 5408999 A AU5408999 A AU 5408999A AU 5408999 A AU5408999 A AU 5408999A
Authority
AU
Australia
Prior art keywords
meiosis
infertility
camp
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54089/99A
Other languages
English (en)
Inventor
Quoc-Lam Cam
Christa Hegele-Hartung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5408999A publication Critical patent/AU5408999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU54089/99A 1998-05-26 1999-05-07 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound Abandoned AU5408999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98250177 1998-05-26
EP98250177 1998-05-26
PCT/EP1999/003138 WO1999061010A2 (fr) 1998-05-26 1999-05-07 TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE

Publications (1)

Publication Number Publication Date
AU5408999A true AU5408999A (en) 1999-12-13

Family

ID=8234594

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54089/99A Abandoned AU5408999A (en) 1998-05-26 1999-05-07 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound

Country Status (7)

Country Link
EP (1) EP1098652A2 (fr)
JP (1) JP2002516272A (fr)
KR (1) KR20010043828A (fr)
AU (1) AU5408999A (fr)
CA (1) CA2333320A1 (fr)
NO (1) NO20005954D0 (fr)
WO (1) WO1999061010A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019354A2 (fr) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition pour fecondation in vitro
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
WO2001038493A1 (fr) * 1999-11-25 2001-05-31 Novo Nordisk A/S Traitement de l'infertilite humaine
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
WO2001062260A2 (fr) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Amelioration d'un taux d'implantation
WO2001076360A2 (fr) * 2000-04-06 2001-10-18 Novo Nordisk A/S Synchronisation de la maturation nucleaire et cytoplasmique d'oocytes in vitro
EP1147774A1 (fr) 2000-04-20 2001-10-24 Stichting Dienst Landbouwkundig Onderzoek Méthode d'amélioration de la qualité du sperme pour l'insémination artificielle des animaux
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
EP1245572A1 (fr) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation
IL162506A0 (en) 2001-12-14 2005-11-20 Applied Research Systems Ovulation induction
WO2003070766A2 (fr) * 2002-02-22 2003-08-28 Novo Nordisk A/S Transducteur de la signalisation de mas
EP2750692B1 (fr) 2011-08-30 2016-08-03 Centre National De La Recherche Scientifique Complexe protéinique comprenant des protéines mcm8 et mcm9 et leur utilisation
GB201117453D0 (en) * 2011-10-10 2011-11-23 Univ Dundee Improved sperm function/activity
CN108531447B (zh) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 调节精子运动能力及辅助生殖的化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196530A3 (fr) * 1985-03-26 1989-03-22 CTA Finanz AG Agent et procédé pour augmenter la croissance, optimiser la fécondité et stimuler le système immunitaire chez les humains et les animaux
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
KR19980702624A (ko) * 1995-03-06 1998-08-05 슈타르 피아 감수분열의 자극
US5800625A (en) * 1996-07-26 1998-09-01 Cauldron Limited Partnership Removal of material by radiation applied at an oblique angle
CA2199663C (fr) * 1997-03-11 2004-08-10 Ruth Miriam Moses Maturation et fecondation in vitro d'ovocytes mammaliens

Also Published As

Publication number Publication date
WO1999061010A2 (fr) 1999-12-02
WO1999061010A3 (fr) 2000-04-27
KR20010043828A (ko) 2001-05-25
JP2002516272A (ja) 2002-06-04
NO20005954L (no) 2000-11-24
EP1098652A2 (fr) 2001-05-16
CA2333320A1 (fr) 1999-12-02
NO20005954D0 (no) 2000-11-24

Similar Documents

Publication Publication Date Title
AU2951299A (en) Disinfecting compositions and processes for disinfecting surfaces
AU7582398A (en) Composition for treating skin conditions
AU2339699A (en) Aqueous metal treatment composition
GB9821217D0 (en) Treatment for substrates
AU1424200A (en) Compounds
AU5408999A (en) Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
AU4501699A (en) Aminoazole compounds
AU1772399A (en) Well treatment
AU3123697A (en) Angiostatic compounds
AUPP433398A0 (en) Compounds and processes
AU1434500A (en) Compounds
AU5056099A (en) Compounds for use in the treatment of inflammation
AU1560200A (en) Disinfecting agents
AU2656799A (en) Metal-thiols as imminomodulating agents
AU7432698A (en) Disinfectant composition
AU2333099A (en) Aryloxyanilides and related compounds
GB9816252D0 (en) Molluscicidal composition
AU1940800A (en) Combination therapy for the treatment of sepsis
AU5757799A (en) Weed-controlling agents
AU5056199A (en) Molluscicidal composition
AU2641099A (en) Imidazoquinazoline derivatives
AU2680200A (en) Treating metal surfaces
AUPP375198A0 (en) An anticorrosion treatment
AU2648899A (en) Composition
AU5524399A (en) Inorgasmia treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase